Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Twist Bioscience Corp buy The Goldman Sachs Group, Inc.

Start price
€31.74
17.01.24 / 50%
Target price
€41.41
17.01.25
Performance (%)
30.72%
Price
€41.49
06.05.24
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Twist Bioscience Corp has seen massive gains of 30.72%. This prediction currently runs until 17.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Twist Bioscience Corp 38.809% 38.809%
iShares Core DAX® 0.476% -0.039%
iShares Nasdaq 100 1.290% 0.504%
iShares Nikkei 225® 1.300% -2.135%
iShares S&P 500 0.829% 0.193%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Twist Bioscience Corp diskutieren
Prediction Buy
Perf. (%) 30.72%
Target price 41.409
Change
Ends at 17.01.25

Twist Bioscience Co. (NASDAQ: TWST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $25.00.
Ratings data for TWST provided by MarketBeat